(Bloomberg) -- Traders are almost 100% certain that Amgen Inc. will complete its $28 billion takeover of Horizon Therapeutics Plc after the Federal Trade Commission paused its in-house case to block the deal.Most Read from BloombergChina’s Worsening Economic Slowdown Is Rippling Across the Globe3M Agrees to Pay More Than $5.5 Billion Over Combat EarplugsTraders Have S&P 500 Comebacks Fading at Historic PaceAuto Union Boss Wants 46% Raise, 32-Hour Work Week in ‘War’ Against Detroit CarmakersTrump

Related Keywords

Bloomberg Businessweek , Gregory Renza , A July Bloomberg , Brett Buckley , Buckley , Bloomberg , Amgen Inc , Pfizer Inc , Horizon Therapeutics Plc , Amgen , Seagen Inc , Federal Trade Commission , Amgen Horizon Deal Challenge Paused , July Bloomberg , Lina Khan Is Upending Wall Street , Horizon ,